Blog

Ola Electric Shares Slide to Over Two-Month Low After Q2 Revenue Falls 43% Shares of Ola Electric Ltd. slipped on Friday morning to hit over two-month low after the company reported its second-quarter numbers, which saw the electric vehicle manufacturer post a 43% decline in revenue at Rs 690 crore from Rs 1,214 crore reported […]

Studds Accessories Shares Debut At 3% Discount Over IPO Price Studds Accessories Ltd. listed on the National Stock Exchange on Friday at Rs 565 apiece, a discount of 3.42% over its issue price of Rs 585 apiece. On the BSE, the stock debuted at Rs 570, a 2.56% discount. The initial public offering (IPO) of

Syngene International Q2 Review: Yes Securities Upgrades Stock to ‘Neutral’ Syngene International, a leading Indian biotechnology company, has been making significant strides in expanding its capabilities and augmenting its capacity in biologics. The company has commenced operations at its Unit III in Bengaluru, which is expected to contribute to its overall growth in the coming

Bharti Airtel Shares Fall Over 4% After Singtel Reportedly Offloads Stake Worth Rs 10,915 Crore The shares of Bharti Airtel Ltd. fell 4.35% on Friday after Singtel reportedly offloaded stake worth Rs 10,195 crore (Singaporean $1.15 billion). Singtel likely sold 0.8% stake in the telecom giant, reported Bloomberg. This significant development has sparked concerns among

LIC Q2 Review: ICICI Securities Maintains ‘Buy’ Call, Sees 23% Upside – Check Target Price Life Insurance Corporation of India (LIC) has witnessed a significant growth in its annual premium equivalent (APE) in the first half of FY26, with a 3.6% year-on-year (YoY) increase. The company’s strategic initiatives have also tracked well consistently, leading ICICI

GSK Pharma Q2 Review: A Closer Look at the Numbers GlaxoSmithKline Pharmaceuticals Ltd. recently reported its Q2 results, which showed a decline in revenue on a year-over-year (YoY) basis. This decline can be attributed to certain one-time events such as the GST transition and the fire incident at GSK Pharma’s contract manufacturing facility. Despite the

Piramal Finance Relists On Stock Exchanges At 12% Premium Piramal Finance, a wholly-owned subsidiary of Piramal Enterprises, has relisted on the stock exchanges at a 12% premium. The shares debuted at Rs 1,260 per share on the NSE, compared to the discovered price of Rs 1,124.20. As of 10:50 a.m., the shares were trading 17.59%

MAS Financial Q2 Review: Strong Growth Prospects Ahead MAS Financial Services Ltd. has reported its Q2 results, and Axis Securities has reiterated its ‘Buy’ call on the stock. The brokerage firm expects strong growth prospects for the company, driven by a robust distribution network and adequate capitalization. The stock currently trades at 1.7x FY27E BV,

Motilal Oswal Downgrades Updater Services To ‘Neutral’ Amid Guidance Cuts, Near-Term Headwinds Updater Services Ltd. recently reported its Q2 FY26 results, which fell short of expectations. The company’s revenue grew 7% year-over-year (YoY) to Rs 7.3 billion, below the estimated Rs 7.7 billion. The core Ebitda margin came in at 4.3%, down 130 basis points

Zydus Lifesciences Q2 Review: A Mixed Bag for Investors Zydus Lifesciences Ltd. recently announced its Q2 FY26 results, which were a mixed bag for investors. While the company’s revenue beat estimates, its margins were subdued due to the lower revenue of gRevlimid and the impact of recent acquisitions in the consumer wellness and medtech divisions.